Advertisement PEPID introduces duplicate therapy checker - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PEPID introduces duplicate therapy checker

PEPID, a provider of drug data and clinical decision support information and technology for healthcare systems and professionals, has added duplicate therapy checking to its drug interaction checker.

In addition to the drug-drug, drug-allergy, drug-food and drug-herbal checks, PEPID’s drug interaction checker also provides alerts for duplicate therapy on three different levels -therapeutic class, pharmacologic class and the ingredient level.

The duplicate therapy check allows electronic medical record or pharmacy information systems to give users a warning if a duplicate therapy exists.

System developers can use the PEPID software development kit and APIs to programmatically receive critical drug information monographs, dosing calculators, drug interaction, drug-allergy or duplicate therapy information.

PEPID’s clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.